irbesartan, candesartan, telmisartan, and eprosartan). These data came from 40 clinical trials. Second, we analyzed publications on randomized, controlled clinical trials conducted with AII ...
Several AT-II-receptor antagonists have been compared with several ACE inhibitors ( Table 2). A double- blind, multicenter, randomized study of 227 patients with mild to moderate hypertension ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback